NCT02786901View on ClinicalTrials.gov

LE Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

June 13, 2017

Study Completion Date

July 1, 2017

Conditions
CataractPainOcular Inflammation
Interventions
DRUG

Loteprednol Etabonate Ophthalmic Gel dosed TID

Gel

DRUG

Loteprednol Etabonate Ophthalmic Gel dosed BID

Gel

DRUG

Vehicle Gel

Gel

Trial Locations (6)

33143

Valeant Site 05, Miami

63131

Valeant Site 02, St Louis

64111

Valeant Site 06, Kansas City

85032

Valeant Site 01, Phoenix

92056

Valeant Site 03, Oceanside

02169

Valeant Site 04, Quincy

All Listed Sponsors
lead

Bausch & Lomb Incorporated

INDUSTRY

NCT02786901 - LE Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery | Biotech Hunter | Biotech Hunter